DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Gangarapu V, Ince AT, Baysal B. et al.
Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.
Eur J Gastroenterol Hepatol 2015;
27 (07) 840-845
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.